StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
1069.HK$0.30+0.00%
Fair $0.30+0.0%

1069.HK

China Health Technology Group Holding Company Limited

Basic Materials / Lumber & Wood ProductionHKSE

$0.30

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.30Fund rank 24/100 · Data gapFallback financials|
SA 43/C
F-Score: 6/9
High Debt

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 18%

FCF escenarios

weak_data · normalized FCF $28.6M · quality 32.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 45/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

43/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific holding-company NAV/SOTP model required: targets are disabled until look-through holdings, debt and discount data exists. Debt-to-Equity ratio is 2.49, above the 2.0 threshold
Thesis & Journal · 1069.HKLocal privado en este navegador · China Health Technology Group Holding Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$36M

P/E

1.2x

↓

EV/EBITDA

4.5x

↓

ROE

48.6%

↑

Gross Margin

9.1%

↓

Debt/Equity

2.49

↑
52-Week Range$0
$0$1

TradingView lightweight chart

1069.HK price, volumen y niveles de valoración

Último $0.300Periodo -99.7%
Fair value: $0.300

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+137.2%

FCF CAGR

—

FCF margin

37.2%

FCF / Net income

1.48x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $90.2M · net income $22.7M · FCF $33.6M

2022-FY → 2025-FY

Gross margin

9.1%— pts

Operating margin

-9.2%+164.1% pts

Net margin

25.2%+304.9% pts

FCF margin

37.2%+44.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$90.2M$90.2M$47.6M$58.7M$6.8M
Net Income$22.7M$22.7M$200.0M$-10.8M$-18.9M
EBITDA$31.3M$31.3M$208.4M$4.8M$2.6M
EPS0.230.232.52-0.83-1.45
Gross Margin9.1%9.1%4.0%19.6%—
Operating Margin-9.2%-9.2%-44.1%-14.3%-173.3%
Net Margin25.2%25.2%420.1%-18.4%-279.8%
Balance Sheet
Debt/Equity2.492.499.19-1.13-1.05
Current Ratio1.341.34———
Cash Flow
Free Cash Flow$33.6M$33.6M$28.6M$22.2M$-466000.00
Returns
ROE48.6%48.6%1543.0%3.4%6.2%
Valuation
P/E1.151.150.25——
EV/EBITDA4.514.510.7999.94176.85
P/B0.630.633.80——
Growth & Yield
Revenue Growth89.5%89.5%-18.9%769.1%—
EPS Growth-90.8%-90.8%404.0%42.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-51.5%

fácil

EPS terminal req.

$0.03

Spread vs growth

-39.3%

5Y implied EPS CAGR

-32.7%

fácil

EPS terminal req.

$0.03

Spread vs growth

-58.1%

10Y implied EPS CAGR

-13.9%

fácil

EPS terminal req.

$0.05

Spread vs growth

-76.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -36.2%

Total return

-36.2%

Start / end P/E

0.2x → 1.3x

EPS bridge

2.52 → 0.23

Residual

-536.9%

EPS growth-90.8%
Multiple rerating+591.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term-536.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.